BUSINESSDESK.CO.NZ
Rua BioScience shareholders have signed off on the $10 million equity purchase of cannabis firm Zalam Therapeutics. The deal, announced Nov 30, will the Gisborne based medicinal cannabis firm issue 24.42m new shares at 41 cents a share.